Hernán A. Navarro

3.7k total citations
123 papers, 3.1k citations indexed

About

Hernán A. Navarro is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Hernán A. Navarro has authored 123 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 54 papers in Cellular and Molecular Neuroscience and 20 papers in Organic Chemistry. Recurrent topics in Hernán A. Navarro's work include Receptor Mechanisms and Signaling (49 papers), Nicotinic Acetylcholine Receptors Study (38 papers) and Neuropeptides and Animal Physiology (28 papers). Hernán A. Navarro is often cited by papers focused on Receptor Mechanisms and Signaling (49 papers), Nicotinic Acetylcholine Receptors Study (38 papers) and Neuropeptides and Animal Physiology (28 papers). Hernán A. Navarro collaborates with scholars based in United States, United Kingdom and Indonesia. Hernán A. Navarro's co-authors include F. Ivy Carroll, S. Wayne Mascarella, Bruce E. Blough, F. Ivy Carroll, Billy R. Martin, Ronald J. Lukas, T A Slotkin, Philip Abraham, F J Seidler and Lawrence E. Brieaddy and has published in prestigious journals such as PLoS ONE, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Hernán A. Navarro

121 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hernán A. Navarro United States 31 1.6k 837 829 453 328 123 3.1k
Maribel Antonello Rubin Brazil 38 1.2k 0.7× 518 0.6× 927 1.1× 805 1.8× 796 2.4× 116 4.1k
Barbara Filipek Poland 29 981 0.6× 911 1.1× 628 0.8× 363 0.8× 430 1.3× 167 2.7k
Kejun Cheng China 37 1.6k 1.0× 476 0.6× 1.2k 1.5× 825 1.8× 773 2.4× 138 4.1k
Mary Chebib Australia 41 2.4k 1.5× 653 0.8× 2.2k 2.7× 745 1.6× 432 1.3× 146 5.0k
Shiro Urano Japan 37 1.3k 0.8× 924 1.1× 303 0.4× 305 0.7× 621 1.9× 100 3.8k
Neal Castagnoli United States 35 1.3k 0.8× 1.1k 1.3× 1.4k 1.7× 531 1.2× 401 1.2× 152 4.7k
Agata Siwek Poland 30 1.4k 0.8× 1.3k 1.6× 804 1.0× 734 1.6× 231 0.7× 214 3.5k
Cornelis J. Van der Schyf United States 34 1.1k 0.7× 716 0.9× 629 0.8× 571 1.3× 411 1.3× 87 2.9k
Angela De Sarro Italy 34 984 0.6× 558 0.7× 1.0k 1.2× 365 0.8× 457 1.4× 75 3.2k
Elsebet Ø. Nielsen Denmark 34 2.6k 1.6× 801 1.0× 2.5k 3.1× 423 0.9× 418 1.3× 85 4.5k

Countries citing papers authored by Hernán A. Navarro

Since Specialization
Citations

This map shows the geographic impact of Hernán A. Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hernán A. Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hernán A. Navarro more than expected).

Fields of papers citing papers by Hernán A. Navarro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hernán A. Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hernán A. Navarro. The network helps show where Hernán A. Navarro may publish in the future.

Co-authorship network of co-authors of Hernán A. Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of Hernán A. Navarro. A scholar is included among the top collaborators of Hernán A. Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hernán A. Navarro. Hernán A. Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kormos, Chad M., Pauline W. Ondachi, Scott P. Runyon, et al.. (2018). Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3R)-N-[1R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic). Journal of Medicinal Chemistry. 61(17). 7546–7559. 4 indexed citations
2.
Ondachi, Pauline W., Chad M. Kormos, Scott P. Runyon, et al.. (2018). Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3R)-7-Hydroxy-N-[(1S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic). Journal of Medicinal Chemistry. 61(17). 7525–7545. 8 indexed citations
3.
Kormos, Chad M., Pauline W. Ondachi, Scott P. Runyon, et al.. (2017). Simple Tetrahydroisoquinolines Are Potent and Selective Kappa Opioid Receptor Antagonists. ACS Medicinal Chemistry Letters. 8(7). 742–745. 9 indexed citations
4.
Kormos, Chad M., Scott P. Runyon, James B. Thomas, et al.. (2016). Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of replacement of the 3-hydroxyphenyl group with pyridine or thiophene bioisosteres. Bioorganic & Medicinal Chemistry. 24(16). 3842–3848. 4 indexed citations
5.
Mascarella, S. Wayne, et al.. (2015). Quantitative Signaling and Structure-Activity Analyses Demonstrate Functional Selectivity at the Nociceptin/Orphanin FQ Opioid Receptor. Molecular Pharmacology. 88(3). 502–511. 30 indexed citations
6.
Carroll, F. Ivy, Chad M. Kormos, Rangan Maitra, et al.. (2015). Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3- and 4-methyl substituents. Bioorganic & Medicinal Chemistry. 23(19). 6379–6388. 14 indexed citations
7.
Ponnala, Shashikanth, et al.. (2014). Evaluation of structural effects on 5-HT2A receptor antagonism by aporphines: Identification of a new aporphine with 5-HT2A antagonist activity. Bioorganic & Medicinal Chemistry Letters. 24(7). 1664–1667. 16 indexed citations
8.
Damaj, M. Imad, Hernán A. Navarro, Robert E. Vann, et al.. (2010). Effects of Hydroxymetabolites of Bupropion on Nicotine Dependence Behavior in Mice. Journal of Pharmacology and Experimental Therapeutics. 334(3). 1087–1095. 40 indexed citations
9.
Blough, Bruce E., et al.. (2010). In vitro and in vivo characterization of a novel negative allosteric modulator of neuronal nAChRs. Neuropharmacology. 59(6). 511–517. 7 indexed citations
10.
Navarro, Hernán A., James L. Howard, Gerald T. Pollard, & F. Ivy Carroll. (2009). Positive allosteric modulation of the human cannabinoid (CB 1 ) receptor by RTI‐371, a selective inhibitor of the dopamine transporter. British Journal of Pharmacology. 156(7). 1178–1184. 70 indexed citations
11.
Jin, Chunyang, Hernán A. Navarro, & F. Ivy Carroll. (2009). Synthesis and structure–activity relationship of 3β-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3β-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters. Bioorganic & Medicinal Chemistry. 17(14). 5126–5132. 5 indexed citations
12.
Chaudhary, Sandeep, et al.. (2009). (±)-Nantenine analogs as antagonists at human 5-HT2A receptors: C1 and flexible congeners. Bioorganic & Medicinal Chemistry Letters. 19(9). 2530–2532. 21 indexed citations
13.
Lewin, Anita H., Hernán A. Navarro, & Brian P. Gilmour. (2009). Amiodarone and its putative metabolites fail to activate wild type hTAAR1. Bioorganic & Medicinal Chemistry Letters. 19(20). 5913–5914. 6 indexed citations
14.
Carroll, F. Ivy, Wei Ma, Jeffrey R. Lee, et al.. (2007). Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3′-(substituted phenyl)deschloroepibatidine analogs. Bioorganic & Medicinal Chemistry. 16(2). 746–754. 15 indexed citations
16.
Navarro, Hernán A., Patricia V. Basta, F J Seidler, & T A Slotkin. (2001). Adolescent nicotine: deficits in immune function. Developmental Brain Research. 130(2). 253–256. 7 indexed citations
17.
Slotkin, T A, Hernán A. Navarro, E.C. McCook, & F J Seidler. (1990). Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. Life Sciences. 47(17). 1561–1567. 44 indexed citations
18.
Seidler, F J, S.E. Lappi, M.I. Tayyeb, Slotkin Ta, & Hernán A. Navarro. (1989). Effects of fetal nicotine exposure on development of adrenergic receptor binding in rat brain regions: selective changes in a1-receptors. 11(3). 95–103. 21 indexed citations
19.
Navarro, Hernán A., et al.. (1989). Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Research Bulletin. 23(3). 187–192. 149 indexed citations
20.
Lau, Christopher, Frederic J. Seidler, Hernán A. Navarro, et al.. (1988). Nutritional Influences on Adrenal Chromaffin Cell Development: Comparison with Central Neurons. Pediatric Research. 24(5). 583–587. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026